Literature DB >> 8474024

Induction of tolerance to crotoxin in mice.

M Okamoto1, L J Viskatis, G de la Roza, J C Vidal.   

Abstract

Crotoxin, the major toxic component from the venom of Crotalus durissus terrificus is a potent neurotoxin (LD50, i.p., mice, 0.09 mg/kg) which possesses phospholipase A2 activity and causes a blockade of neuromuscular transmission. In this article, we show that mice injected daily with progressively increasing doses of crotoxin develop tolerance to the lethal action of this toxin. Treated mice tolerated daily doses of crotoxin 20- to 35-fold higher than the original LD50 without the characteristic signs of toxicity. Studies on the isolated phrenic nerve-diaphragm preparation in vitro from control (crotoxin-naive) mice showed that the exposure to 2 to 10 micrograms/ml crotoxin in the bath produced complete transmission blockade in 120 to 150 min. Conversely, the preparations from crotoxin-treated mice required crotoxin concentrations in the range of 17.5 to 100 micrograms/ml to produce complete neuromuscular block, being virtually insensitive during 200 min of exposure to 5 to 10 micrograms/ml crotoxin. Phrenic nerve-diaphragm preparations of control (crotoxin-naive) and crotoxin-treated mice did not show significant differences in sensitivity to the blocking action of carbamylcholine, suggesting that induction of tolerance to crotoxin is likely a presynaptic event.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474024

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  In vitro comparison of cytotoxic effects of crotoxin against three human tumors and a normal human epidermal keratinocyte cell line.

Authors:  C J Rudd; L J Viskatis; J C Vidal; M A Etcheverry
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

2.  VRCTC-310--a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity.

Authors:  R A Newman; J C Vidal; L J Viskatis; J Johnson; M A Etcheverry
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

3.  Analysis of nociceptive effects of neurotoxic phospholipase A2 from Vipera nikolskii venom in mice.

Authors:  Igor A Dyachenko; Arkadii N Murashev; Tatyana V Andreeva; Victor I Tsetlin; Yuri N Utkin
Journal:  J Venom Res       Date:  2013-03-15

4.  Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study.

Authors:  Jacques Medioni; Mara Brizard; Reza Elaidi; Paul F Reid; Khadija Benlhassan; Dorothy Bray
Journal:  Contemp Clin Trials Commun       Date:  2017-07-23

5.  Crotoxin Conjugated to SBA-15 Nanostructured Mesoporous Silica Induces Long-Last Analgesic Effect in the Neuropathic Pain Model in Mice.

Authors:  Morena Brazil Sant'Anna; Flavia Souza Ribeiro Lopes; Louise Faggionato Kimura; Aline Carolina Giardini; Osvaldo Augusto Sant'Anna; Gisele Picolo
Journal:  Toxins (Basel)       Date:  2019-11-20       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.